ePRO, E-Patient Diaries and eCOA Market Perceive Robust Expansion by 2026
Electronic Clinical Outcome Assessment (eCOA) measures patient symptoms, overall mental state, and the effects of a disease condition.
New York, NY -- (SBWire) -- 06/15/2017 --Patient data collected in traditional paper diaries is compromised due to illegibility, inappropriate and illogical responses from respondents. Paper diary data needs to be transcribed into an electronic system for analysis which increases time consumed in overall data analysis. Electronic Clinical Outcome Assessment (eCOA) is a next generation technology which significantly improvises the quality of data captured from patients, clinicians and physicians. Electronic Patient Reported Outcomes (ePRO) is a type of eCOA in which an electronically generated patient data irrespective of patient location, therapies and time of the day. ePRO captures patient data directly from patients easily by designing effective reporting forms and questionnaires for respondents to complete their E-Patient Diaries while specifying time and frequency of data input. ePRO system provides a secure platform for entering information in the E-Patient Diaries via a computer, tablet, smartphone or any other device to enhance patient compliance.
To view complete report @ http://www.persistencemarketresearch.com/market-research/epro-epatient-diaries-and-ecoa-market.asp
EPRO, E-Patient Diaries and eCOA Market: Drivers & Restraints
Electronic Clinical Outcome Assessment (eCOA) measures patient symptoms, overall mental state, and the effects of a disease condition. Electronic diaries aids in documentation of patient response. Electronic diaries are an important support for ePRO. Compliance rates are usually 90% and above in eCOA applications. A significant factor of ePRO is that it detects future adverse conditions of patients in advance. These technologies are beneficial in providing real-time data from the respondents for better evaluation and accurate decision making thus, driving growth of the ePRO, E-Patient Diaries and eCOA market.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/11506
EPRO, E-Patient Diaries and eCOA Market: Overview
With the advent of technologies such as EPRO, E-Patient Diaries and eCOA, transcription errors have been reduced remarkably. These technologies enable delivery of customized solutions, personalized experiences and supports global services. The questionnaires used in ePRO are longer and more complex than those used in patient diaries, an important reason being the branching logic of ePRO. As a result, ePRO segment is projected to grow at a significant CAGR. ePROs are most commonly used in clinical trials and consumer healthcare projects and the collective share of these two segments is expected to be around half the global market share.
EPRO, E-Patient Diaries and eCOA Market: Region wise Overview
Geographically, global ePRO, E-Patient Diaries and eCOA market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, Middle East and Africa (MEA). U.S. is expected to lead the market in terms of value owing to the presence of large number of companies which are consistently leveraging the scientific capabilities of eCOA such as development, modification and validation of instruments, identification of suitable instruments to meet study requirements, studying the designs in accordance with PRO Good Research Practices and further analysis and interpretation of data from different types of PROs.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/11506
EPRO, E-Patient Diaries and eCOA Market: Key Players
Key players in global ePRO, E-Patient Diaries and eCOA market are ERT Clinical, Biomedical Systems, Bracket, Exco InTouch Ltd, CRF Health, Almac Group, PAREXEL International Corporation, HealthDiary Inc., Medidata Solutions, Inc. to name a few.
Media Relations Contact
Persistence Market Research Pvt. Ltd.
View this press release online at: http://rwire.com/819793